Resultados de la búsqueda 391-400 of 13644 for Rubella

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this trial is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  3. Dermatología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop a registry to collect long-term data on patients with pediatric cutaneous mastocytosis, and develop better knowledge ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. · To evaluate the clinical outcomes related to IIC, including the ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called ...

  6. Mayo Clinic

    Share · Tweet . VID-20312300. Inicio; YouTube-Patient Shuttle - Mayo Clinic Patient Video Guide - Minnesota. Tu donación es muy poderosa.

  7. Roséola - Diagnóstico y tratamiento - Mayo Clinic

    Paño frío o baño de esponja. Dé a su hijo un baño de esponja tibio, o colóquele un paño húmedo y fresco en la frente. Esto puede aliviar el malestar causado por ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...